» Articles » PMID: 38555419

Hypoxia Inducible Factor-1α Regulates Microglial Innate Immune Memory and the Pathology of Parkinson's Disease

Overview
Publisher Biomed Central
Date 2024 Mar 30
PMID 38555419
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroinflammation is one of the core pathological features of Parkinson's disease (PD). Innate immune cells play a crucial role in the progression of PD. Microglia, the major innate immune cells in the brain, exhibit innate immune memory effects and are recognized as key regulators of neuroinflammatory responses. Persistent modifications of microglia provoked by the first stimuli are pivotal for innate immune memory, resulting in an enhanced or suppressed immune response to second stimuli, which is known as innate immune training and innate immune tolerance, respectively. In this study, LPS was used to establish in vitro and in vivo models of innate immune memory. Microglia-specific Hif-1α knockout mice were further employed to elucidate the regulatory role of HIF-1α in innate immune memory and MPTP-induced PD pathology. Our results showed that different paradigms of LPS could induce innate immune training or tolerance in the nigrostriatal pathway of mice. We found that innate immune tolerance lasting for one month protected the dopaminergic system in PD mice, whereas the effect of innate immune training was limited. Deficiency of HIF-1α in microglia impeded the formation of innate immune memory and exerted protective effects in MPTP-intoxicated mice by suppressing neuroinflammation. Therefore, HIF-1α is essential for microglial innate immune memory and can promote neuroinflammation associated with PD.

Citing Articles

Neurodegenerative diseases and neuroinflammation-induced apoptosis.

Huang S, Lu Y, Fang W, Huang Y, Li Q, Xu Z Open Life Sci. 2025; 20(1):20221051.

PMID: 40026360 PMC: 11868719. DOI: 10.1515/biol-2022-1051.


Association Between Hypoxia-Inducible Factor-1α and Neurological Diseases: A Bidirectional Two-Sample Mendelian Randomization Analysis.

Liang J, Du X, Wang M, Zheng H, Sun Y, Lin Y Brain Behav. 2025; 15(3):e70398.

PMID: 40022282 PMC: 11870835. DOI: 10.1002/brb3.70398.


Agmatine suppresses glycolysis via the PI3K/Akt/mTOR/HIF-1α signaling pathway and improves mitochondrial function in microglia exposed to lipopolysaccharide.

Milosevic K, Milosevic A, Stevanovic I, Zivkovic A, Laketa D, Janjic M Biofactors. 2025; 51(1):e2149.

PMID: 39888089 PMC: 11780571. DOI: 10.1002/biof.2149.


Hypoxia Pathways in Parkinson's Disease: From Pathogenesis to Therapeutic Targets.

Gao Y, Zhang J, Tang T, Liu Z Int J Mol Sci. 2024; 25(19).

PMID: 39408813 PMC: 11477385. DOI: 10.3390/ijms251910484.


MiR-199a-5p Deficiency Promotes Artery Restenosis in Peripheral Artery Disease by Regulating ASMCs Function Targeting HIF-1α and E2F3.

Liu D, Jing Y, Peng G, Wei L, Zheng L, Chang G Curr Vasc Pharmacol. 2024; 22(5):342-354.

PMID: 38910413 DOI: 10.2174/0115701611280634240616062413.

References
1.
Wendeln A, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G . Innate immune memory in the brain shapes neurological disease hallmarks. Nature. 2018; 556(7701):332-338. PMC: 6038912. DOI: 10.1038/s41586-018-0023-4. View

2.
Jurga A, Paleczna M, Kuter K . Overview of General and Discriminating Markers of Differential Microglia Phenotypes. Front Cell Neurosci. 2020; 14:198. PMC: 7424058. DOI: 10.3389/fncel.2020.00198. View

3.
Corcoran S, ONeill L . HIF1α and metabolic reprogramming in inflammation. J Clin Invest. 2016; 126(10):3699-3707. PMC: 5096812. DOI: 10.1172/JCI84431. View

4.
Norden D, Trojanowski P, Walker F, Godbout J . Insensitivity of astrocytes to interleukin 10 signaling following peripheral immune challenge results in prolonged microglial activation in the aged brain. Neurobiol Aging. 2016; 44:22-41. PMC: 5467746. DOI: 10.1016/j.neurobiolaging.2016.04.014. View

5.
Cho S, Chen J, Sayed F, Ward M, Gao F, Nguyen T . SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1β. J Neurosci. 2015; 35(2):807-18. PMC: 4293425. DOI: 10.1523/JNEUROSCI.2939-14.2015. View